Skip to content
Clinical Trials – home
PolandBack to Poland

Clinical trials in Torun – page 69

918 clinical trials in Torun, Poland across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

PolandOur site in PolandBadaniaKliniczne.pl(opens in a new tab)
Torun at a glance
918
clinical trials
  • Research sites2
Type of trial
Recruitment status
Quick filters

918 trials in Torun

Open in trial search

Multiple sclerosis

Not recruiting

Study on Long-Term Safety and Efficacy of Ocrelizumab for Patients with Multiple Sclerosis

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years
  • Substances:Ocrelizumab
  • Sponsor:F. Hoffmann-La Roche AG

Study on Ofatumumab for Patients with Relapsing Multiple Sclerosis Transitioning from Fumarate-Based Therapies or Fingolimod

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years
  • Substances:Ofatumumab
  • Sponsor:Novartis Pharma AG

Plasma cell myeloma+13

Not recruiting

Study on Atezolizumab and Drug Combinations for Advanced Malignancies in Patients from Previous Atezolizumab Trials

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Alectinib
  • Sponsor:F. Hoffmann-La Roche AG

Dry eye+1

Not recruiting

Study on the Effectiveness and Safety of Ianalumab for Patients with Active Sjögren’s Syndrome

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Ianalumab
  • Sponsor:Novartis Pharma AG

Study of Ziftomenib (KO-539) in Patients with Relapsed or Refractory Acute Myeloid Leukemia

InvestigationalNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Ziftomenib
  • Sponsor:Kura Oncology Inc.

Dry eye+1

Not recruiting

Study on the Effectiveness and Safety of Ianalumab for Patients with Active Sjögren’s Syndrome

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Ianalumab
  • Sponsor:Novartis Pharma AG

Deafness neurosensory

Not recruiting

Study on the Effectiveness and Safety of AC102 Injection vs. Oral Prednisolone for Patients with Sudden Hearing Loss

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:AC102
  • Sponsor:AudioCure Pharma GmbH

Polycythaemia vera

Not recruiting

Study on the Effects of Sapablursen for Patients with Phlebotomy Dependent Polycythemia Vera

InvestigationalNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Sapablursen
  • Sponsor:Ionis Pharmaceuticals Inc.

Breast cancer

Not recruiting

Study on Alpelisib and Fulvestrant for Men and Postmenopausal Women with Advanced HR-positive, HER2-negative Breast Cancer with PIK3CA Mutation

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Alpelisib
  • Sponsor:Novartis Pharma AG

Study on Obinutuzumab, Chlorambucil, and Acalabrutinib for Patients with Untreated Chronic Lymphocytic Leukemia

Registered drugNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Acalabrutinib
  • Sponsor:Acerta Pharma B.V.

Psoriatic arthropathy

Not recruiting

Study on Long-Term Safety and Effectiveness of Bimekizumab for Adults with Active Psoriatic Arthritis

InvestigationalNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Bimekizumab
  • Sponsor:UCB Biopharma

Study on Golcadomide and R-CHOP Drug Combination for Patients with Untreated High-risk Large B-cell Lymphoma

Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Apixaban
  • Sponsor:Celgene Corp.

Other cities in Poland

The busiest research cities in the country

All 236 cities in Poland

Clinical research in Torun

What the registry says about research in the country

01 Infectious Disease Prevention

Clinical research focusing on vaccine development for various infectious diseases, including studies on chickenpox, meningococcal, and pneumococcal vaccines. Trials evaluate immune responses in children and toddlers.

  • Varicella vaccine studies
  • Meningococcal ACYW research
  • Pneumococcal conjugate vaccines

These studies aim to enhance protection against common childhood infections through innovative immunization strategies.

02 Autoimmune Conditions

Extensive research into treatments for inflammatory disorders, with particular focus on novel therapies for conditions affecting joints and skin.

  • Psoriatic Arthritis treatments
  • Ulcerative Colitis therapies
  • Atopic Dermatitis solutions

Clinical trials are evaluating new biological and small molecule treatments to improve patient outcomes.

03 Oncology and Hematology

Advanced research in blood cancers and related conditions, focusing on innovative therapeutic approaches.

  • Acute Myeloid Leukemia treatments
  • Chronic Lymphocytic Leukemia therapies
  • Prostate Cancer interventions

Studies evaluate combination therapies and novel compounds for improved treatment outcomes.

04 Chronic Disease Management

Research targeting long-term conditions affecting quality of life, including cardiovascular and joint disorders.

  • Heart Failure prevention
  • Osteoarthritis treatments
  • IgA Nephropathy studies

Trials focus on developing therapeutic solutions for chronic condition management.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.